North American ginseng (Panax quinquefolius) prevents hyperglycemia and associated pancreatic abnormalities in diabetes

Journal of Medicinal Food

Volumn 16, Issue 7, 2013, Pages 587-592

  Sen, Subhrojit ^a   Querques, Maria Anna ^a   Chakrabarti, Subrata ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

C peptide; diabetes; insulin; North American ginseng; pancreas

Indexed keywords

ANTIDIABETIC AGENT; C PEPTIDE; GINSENG EXTRACT; GINSENOSIDE RB 1; GINSENOSIDE RB 2; GINSENOSIDE RD; GINSENOSIDE RE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; PANAX QUINQUEFOLIUS ROOT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANAX QUINQUEFOLIUS; PANCREAS DISEASE; PANCREAS ISLET BETA CELL; PHYTOCHEMISTRY; PLANT ROOT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STREPTOZOCIN DIABETES; WEIGHT GAIN; WEIGHT REDUCTION;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MICE; MICE, INBRED C57BL; PANAX; PANCREAS; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 84880774100     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.0192     Document Type: Article

References (35)

1. Ritzel RA: Therapeutic approaches based on beta-cell mass preservation and/or regeneration. Front Biosci 2009;14:1835-1850
2. Yoon JW, Jun HS: Autoimmune destruction of pancreatic beta cells. Am J Ther 2005;12:580-591
3. Wajchenberg BL: Beta-cell failure in diabetes and preservation by clinical treatment. Endocr Rev 2007;28:187-218
4. Cheng Y, Shen LH, Zhang JT: Anti-Amnestic and anti-Aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacol Sin 2005;26:143-149
5. Choo MK, Park EK, Han MJ, Kim DH: Antiallergic activity of ginseng and its ginsenosides. Planta Med 2003;69:518-522
6. Jeong HJ, Koo HN, Myung NI, et al.: Inhibitory effects of mast cell-mediated allergic reactions by cell cultured Siberian ginseng. Immunopharmacol Immunotoxicol 2001;23:107-117
7. Kimura M, Waki I, Chujo T, et al.: Effects of hypoglycemic components in ginseng radix on blood insulin level in alloxan diabetic mice and on insulin release from perfused rat pancreas. J Pharmaco Bio Dyn 1981;4:410-417
8. Xie JT, Mehendale SR, Wang A, et al.: American ginseng leaf: Ginsenoside analysis and hypoglycemic activity. Pharmacol Res 2004;49:113-117
9. Xie JT, Mehendale S, Yuan CS: Ginseng and diabetes. Am J Chin Med 2005;33:397-404
10. Attele AS, Wu JA, Yuan CS: Ginseng pharmacology: Multiple constituents and multiple actions. Biochem Pharmacol 1999;58: 1685-1693
11. Wang AB, Wang CZ, Wu JA, Osinski J, Yuan CS: Determination of major ginsenosides in Panax qiunquefolius using high performance liquid chromatography. Phytochem Anal 2005;16: 272-277
12. Qu CL, Bai YP, Jin XQ, et al.: Studies on ginsenosides in different parts and and ages of Panax qiunquefolius L Food Chem 2009;115:340-346
13. Wang C, Aungi HH, Zhang B, et al.: Chemopreventive effects of heat-processed Panax quinquefolius root on human breast cancer cells. Anticancer Res 2008;28:2545-2552
14. Kim SH, Park SH: Effects of Panax ginseng extract on lipid metabolism in humans. Pharmacol Res 2003;48:511-513
15. Kim YK, Guo Q, Packer L: Free radical scavenging activity of red ginseng aqueous extracts. Toxicology 2002;72:149-156
16. Jung CH, Seog HM, Choi IW, Choi H, Cho HY: Effects of wild ginseng (Panax ginseng C.A. Meyer) leaves on lipid peroxidation levels and antioxidant enzyme activities in streptozotocin diabetic rats. J Ethnopharmacol 2005;98:245-250
17. Vuksan V, Stavro MP, Sievenpiper JL, et al.: American ginseng improves glycemia in individuals with normal glucose tolerance: Effect of dose and time escalation. J Am Coll Nutr 2000;9: 738-744
18. Sen S, Chen S, Feng B, Yuexiu W, Lui EMK, Chakrabarti S: Preventive effects of North American ginseng (Panax quinquefolium) on diabetic nephropathy. Phytomedicine 2012;19: 494-505
19. Sen S, Chen S, Feng B, Yuexiu W, Lui EMK, Chakrabarti S: American ginseng (Panax quinquefolius) prevents glucoseinduced oxidative stress and associated endothelial cell abnormalities. Phytomedicine 2011;18:1110-1117
20. Sen S, Chen S, Feng B, Yuexiu W, Lui EK, Chakrabarti S: Preventive effects of North American ginseng (Panax quinquefolius) on diabetic retinopathy and cardiomyopathy. Phytother Res 2013;27:290-298
21. Azike CG, Charpentier PA, Jirui H, Hua P, Lui EMK: The yin and yang actions of North American ginseng root in modulating the immune function of macrophages. Chin Med 2011;6:21-32
22. Chung SH, Choi CG, Park SH: Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice. Arch Pharm Res 2001;24:214-218
23. Attele AS, Zhou YP, Xie JT, et al.: Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002;51:1851-1858
24. Vuksan V, Sievenpiper JL, Wong J, et al.: American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-Dependent but not dose-Dependent manner in healthy individuals. Am J Clin Nutr 2001;73:753-758
25. Park E, Kim H, Kim Y, et al.: Increase in insulin secretion induced by Panax ginseng berry extracts contributes to the amelioration of hyperglycemia in streptozotoc-induced diabetic mice. J Ginseng Res 2012;36:153-160
26. Zinman B. Glucose control in type 1 diabetes: From conventional to intensive therapy. Clin Cornerstone 1998;1:29-38
27. Vinik A. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy. Clin Ther 2007;29:1236-1253
28. Jain SK, Velusamy T, Croad JL, Rains JL, Bull R: L-cysteine supplementation lowers blood glucose, glycated hemoglobin, CRP,MCP-1, and oxidative stress and inhibitsNF-kappaB activation in the livers of Zucker diabetic rats. Free Radic Biol Med 2009;46:1633-1638
29. Xiong Y, Ling S, Jiu KJ, et al.: Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats. Diabetes 2010; 59:2502-2512
30. Shang W, Yang Y, Zhou L, Jiang B, Jin H, Chen M: Ginsenoside Rb1 stimulates glucose uptake through insulin-Like signaling pathway in 3T3-L1 adipocytes. J Endocrinol 2008;198:561-569
31. Ji QC, Harkey MR, Henderson GL, et al.: Quantitative determination of ginsenosides by high-performance liquid chromatographytandem mass spectrometry. Phytochem Anal 2001;12:320-326
32. Shibata S: Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J Korean Med Sci 2001;16 Suppl:S28-S37
33. Ahmed ABA, Rao AS, Rao MV: In vitro callus and in vivo leaf extract of Gymnema sylvestre stimulates b-cells regeneration and anti-Diabetic activity in Wistar rats. Phytomedicine 2010;17: 1033-1039
34. Ao Y, Chen J, Yue J, Peng RX: Effects of 18alpha-glycyrrhizin on the pharmacodynamics and pharmacokinetics of glibenclamide in alloxan-induced diabetic rats. Eur J Pharmacol 2208;587:330-335
35. Sen S, Roy M, Chakraborti AS: Ameliorative effects of glycyrrhizin on streptozotocin-induced diabetes in rats. J Pharm Pharmacol 2011;63:287-296